Mainstream

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Post ContentcaprRead More

You might also be interested in reading Crypto Payment Firm Simplex Acquired by Publicly-Listed Canadian Firm Nuvei for $250 Million.

May 14, 2025
In Mainstream